Medizen Humancare Co.,Ltd. announced a private placement of 66,667 preferred shares at a price of KRW 15,000 per share for gross proceeds of KRW 1,000,005,000 on February 16, 2017. The transaction will include participation from new investor LSK-BNH Korea Bio fund. The preferred shares being issued have a par value of KRW 500 per share. The shares will be issued through third party allotment. The transaction is expected to close on February 17, 2017. The transaction has been approved by the board of directors of the company. The investor has the rights to redeem the entire or partial amount from February 17, 2020. The redemption period will start on February 17, 2020 and will end on February 17, 2027. The conversion period will start on February 18, 2017 and will end on February 16, 2027.